Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05810870
Title PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin (SABINA)
Acronym SABINA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors MedSIR
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Additional content available in CKB BOOST